13.51
price down icon3.84%   -0.54
after-market Handel nachbörslich: 13.51
loading

Finanzdaten der Vor Biopharma Inc-Aktie (VOR)

Gewinn- und Verlustrechnung
Vierteljährlich
*Alle Zahlen in Millionen
Enddatum des Zeitraums 2025-09-30 2025-06-30 2025-03-31 2024-12-31 2024-09-30
Periodenlänge 3 Monate 3 Monate 3 Monate 3 Monate 3 Monate
Revenues
-
- - - -
Operating Expenses
89.75%
28.11
274.28 33.29 31.31 28.51
Operating Income/Loss
89.75%
-28.11
-274.28 -33.29 -31.31 -28.51
Nonoperating Income/Loss
39.62%
-784.58
-1,299.38 0.805 0.599 0.954
Income/Loss From Continuing Operations Before Tax
48.36%
-812.68
-1,573.67 -32.49 -30.71 -27.56
Income/Loss From Continuing Operations After Tax
48.36%
-812.68
-1,573.67 -32.49 -30.71 -27.56
Net Income/Loss
48.36%
-812.68
-1,573.67 -32.49 -30.71 -27.56
Preferred Stock Dividends And Other Adjustments
-
- - - -
Attributable To Noncontrolling Interest
-
- - - -
Basic Average Shares
94.67%
6.6818
125.27 124.82 0.4396 68.47
Diluted Average Shares
94.67%
6.6818
125.27 124.82 0.4396 68.47
Basic Earnings Per Share
868.39%
-121.63
-12.56 -0.26 -0.44 -0.40
Diluted Earnings Per Share
868.39%
-121.63
-12.56 -0.26 -0.44 -0.40
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic
-
- - - -
$45.65
price down icon 0.48%
$28.06
price down icon 1.72%
$52.56
price down icon 1.55%
$91.19
price up icon 1.21%
$139.50
price down icon 0.01%
biotechnology ONC
$284.05
price down icon 0.44%
Kapitalisierung:     |  Volumen (24h):